Approximately 35 million people worldwide struggle with drug use disorders, often facing difficulties in sustaining long-term recovery. Modafinil, a wakefulness-promoting medication, has emerged as a potential adjunct therapy to help individuals manage cravings and enhance focus.
Ongoing research highlights Modafinil’s potential to improve cognitive control and reduce impulsive behavior in those recovering from addiction. By boosting alertness and concentration, Modafinil may offer a novel approach to supporting individuals in overcoming addiction-related challenges and maintaining lasting recovery.




